GRANTS

97 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: NIH will contribute up to $ 95,000 per year toward the salary of the career award recipient, as well as other program-related expenses.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: NINDS will contribute up to $ 95,000 commensurate with salary and effort, as well as fringe benefits during phase II. In Phase I, the NIH will contribute salary commensurate with the applicant institution's salary structure for persons of equivalent qualifications, experience, and rank, up to $50,000 plus fringe benefits per year.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS) (U24)

Sponsor: National Institute on Aging

Award: NIH intends to fund an estimate of one award, corresponding to a total of $1.1 million in direct costs for Fiscal Year 2017. Future year amounts will depend on annual appropriations.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Independent Scientist Award (Parent K02)

Sponsor: National Institutes of Health

Due Date: Standard dates apply, with the first due date on June 12, 2016), by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Mentored Research Scientist Development Award (Parent K01)

Sponsor: National Institutes of Health

Due Date: Standard dates apply, with the first due date on June 12, 2016, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R41/R42)

Sponsor: Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Award: Up to $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. Note new SBIR/STTR standard due dates.

Tools for Cell Line Identification (R43/R44

Sponsor: National Institute of General Medical Sciences, National Center for Advancing Translational Sciences, National Cancer Institute, National Institute on Aging, National Institute of Allergy and Infectious Diseases, National Institute of Biomedical Imaging and Bioengineering, National Institute on Drug Abuse, National Institute of Dental and Craniofacial Research, National Institute of Neurological Disorders and Stroke, Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs, Office of Research on Women's Health

Award: Up to 150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50% ($225,000 for Phase I and $1,500,000 for Phase II).

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. Note new SBIR/STTR standard due dates.

Development and Commercialization of Technologies to Create, Characterize or Improve Animal Models of Human Disease (R43/R44)

Sponsor: Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs

Award: Total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50 percent ($225,000 for Phase I and $1,500,000 for Phase II).

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. (Note new SBIR/STTR standard due dates.)

Mentored Patient-Oriented Research Career Development Award (Parent K23)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, with the first due date on June 12, 2016, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

NIH Pathway to Independence Award (Parent K99/R00)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, with the first due date on June 12, 2016, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Preclinical Drug Discovery RFP

Sponsor: Alzheimer's Drug Discovery Foundation

Award: $150,000-$600,000

Due Date: Letter of Intent: May 13, 2016 Invited Full Proposal: June 3, 2016

ADDF/NIH RFP

Sponsor: Alzheimer's Drug Discovery Foundation

Award: Varies

Due Date: Proposals accepted on a rolling basis

Current Filters

No filters selected

Filter By